1. Home
  2. AMCI vs ATOS Comparison

AMCI vs ATOS Comparison

Compare AMCI & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMC Robotics Corporation Common Stock

AMCI

AMC Robotics Corporation Common Stock

N/A

Current Price

$0.82

Market Cap

26.3M

Sector

Finance

ML Signal

N/A

Logo Atossa Therapeutics Inc.

ATOS

Atossa Therapeutics Inc.

N/A

Current Price

$1.80

Market Cap

25.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMCI
ATOS
Founded
2021
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.3M
25.9M
IPO Year
2022
2010

Fundamental Metrics

Financial Performance
Metric
AMCI
ATOS
Price
$0.82
$1.80
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $19.00
AVG Volume (30 Days)
★ 130.9K
48.0K
Earning Date
11-16-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $5,980,847.00
$1,758.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.78
$0.53
52 Week High
$15.75
$7.56

Technical Indicators

Market Signals
Indicator
AMCI
ATOS
Relative Strength Index (RSI) 27.43 31.30
Support Level N/A N/A
Resistance Level $3.99 $2.60
Average True Range (ATR) 0.28 0.17
MACD -0.01 -0.04
Stochastic Oscillator 1.16 1.54

Price Performance

Historical Comparison
AMCI
ATOS

About AMCI AMC Robotics Corporation Common Stock

AMC Robotics Corp is a technology solutions company that offers AI-powered smart security and robotics solutions. It currently sells smart hardware products designed for residential and commercial use, including smart cameras, driving recorders, action cameras, and Retina K cameras, which are marketed under the YI brand. AMC Robotics is also engaged in developing additional hardware products and technology capabilities, including IoT-enabled devices, AI-based features, wearable devices, and AI robotics. Using its technological capabilities, the company is developing robotic dogs, robotic arms, and robotic unloading systems, offering smart solutions for the logistics and warehousing sectors. It has two primary operating segments: North America, which generates maximum revenue, and Europe.

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.

Share on Social Networks: